Clinical efficacy and safety of first-line nilotinib or imatinib therapy in patients with chronic myeloid leukemia-Nationwide real life data.

Petra Belohlavkova Daniela ZackovaHana KlamovaEdgar FaberMichal KarasLukas StejskalEduard CmuntOlga CernaIvana JeziskovaKaterina Machova PolakovaPavel ZakTereza JurkovaMarika ChrapavaJiri Mayer

Published in: Cancer medicine (2024)

This retrospective analysis from clinical practice did not confirm any benefit of frontline nilotinib treatment for OS and PFS; however, it did demonstrate higher FFS and EFS in the nilotinib cohort.

Keyphrases

chronic myeloid leukemia
clinical practice
electronic health record
big data
bone marrow
mesenchymal stem cells
combination therapy
deep learning
cell therapy
smoking cessation